Inventor
MARMSATER FREDRIK P
US10 patents
⚠️ This page may combine multiple inventors who share the name “MARMSATER FREDRIK P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARRAY BIOPHARMA INC
6 patentsUS9693989B2Jul 4, 2017
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
ARRAY BIOPHARMA INC13 citations91
US10780073B2Sep 22, 2020
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
ARRAY BIOPHARMA INC7 citations82
US12171739B2Dec 24, 2024
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
ARRAY BIOPHARMA INC0 citations61
US9809590B2Nov 7, 2017
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
ARRAY BIOPHARMA INC1 citations61
US8895550B2Nov 25, 2014
Triazolopyridine compounds as PIM kinase inhibitors
ARRAY BIOPHARMA INC0 citations40
US8987251B2Mar 24, 2015
Triazolopyridine compounds as PIM kinase inhibitors
ARRAY BIOPHARMA INC0 citations36
ALLEN SHELLEY
2 patentsBOYS MARK LAURENCE
2 patentsUS9174981B2Nov 3, 2015
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
BOYS MARK LAURENCE3 citations58
US8841455B2Sep 23, 2014
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors
BOYS MARK LAURENCE1 citations46